Mode
Text Size
Log in / Sign up
N/A N=29 Supportive Care

A Personalized Self-care Support Program for Primary Care Patients With Diabetic Foot Ulcer

Foot Ulcer

Enrolled (actual)
29
Serious AEs
Results posted
Aug 2025
Primary outcome: Primary: Feasibility of Recruiting and Retaining — 26 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
A personalised self-care support program (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
National Healthcare Group Polyclinics
Primary completion
Jan 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility of Recruiting and Retaining
26
PRIMARY
Acceptability of the Intervention
26
SECONDARY
Patients' Adherence to Foot Self-care Behaviour
20.2
SECONDARY
Patients' Foot Care Confidence (Self-efficacy)
32.7
SECONDARY
Patients' Illness Belief
47.9
SECONDARY
Patients' Perceptions of Autonomy Support
3.5
SECONDARY
Patients' Diabetes Distress
3.5
SECONDARY
Patients' Knowledge of Recognizing Wound Deterioration
7.7
SECONDARY
Patients' Quality of Life
57.3
SECONDARY
HbA1c
83

Summary

This clinical trial aims to learn if a personalized self-care program supporting self-care and Healing through Empowerment and Active Listening (HEALing), is acceptable to patients with diabetic foot ulcer (DFU) and wound care nurses, and is feasible to deliver supportive self-care for primary care patients living with DFU. The main questions it aims to answer are: * Is the personalized self-care improvement program acceptable to patients with diabetic foot ulcer (DFU) and wound care nurses to deliver? * Is the personalized self-care improvement program feasible for supportive self-care for primary care patients living with DFU? Researchers will compare pre-intervention to post-intervention to see if the personalized self-care improvement program works to support self-care management for patients with DFU. Participants will: -receive three 30-minute face-to-face intervention sessions every 2 weeks within 6 weeks after their routine wound care dressing.

Eligibility Criteria

Inclusion Criteria

  • Patients with diabetes and DFU aged 21 years or above receiving treatment and wound care at National Healthcare Group Polyclinics
  • HCPs, who are aged 21 years or above with a patient-facing role working in delivering program (only for qualitative interviews)

Exclusion Criteria

  • Patients have a diagnosis of critical lower limb ischemia, active osteomyelitis, Charcot foot, cognitive/psychiatric diagnoses, and hearing or vision impairment.
  • Pregnant women will be excluded from the study for both patient and HCP groups
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06540170). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search